(Q42999766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

K Lindahl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

O Reichard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

T Carlsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Schvarcz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

316-321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C infection and the patient with end-stage renal disease

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Single-dose pharmacokinetics and tolerability of pegylated interferon-alpha2b in young and elderly healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Chronic hepatitis C: updated Swedish consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

Cardiovascular disease as a late complication of end-stage renal disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00680.X

10.1111/J.1365-2893.2005.00680.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16637862%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference